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Overview of
workbook series
This workbook is part of a series in-
tended to educate programme plan-
ners, managers, staff and other deci-
sion-makers about the evaluation of
services and systems for the treatment
of psychoactive substance use disor-
ders. The objective of this series is to
enhance their capacity for carrying out
evaluation activities. The broader goal
of the workbooks is to enhance treat-
ment efficiency and cost-effectiveness
using the information that comes from
these evaluation activities.
This workbook (Workbook 2) de-
scribes step-by-step methods for
implementing evaluations. These
steps span from starting the study,
to collecting, analysing, and report-
ing the data, to putting the results
into action in your treatment
programme.
Introductory Workbook
Framework Workbook
Foundation Workbooks
Workbook 1: Planning Evaluations
Workbook 2: Implementing Evaluations
Specialised Workbooks
Workbook 3: Needs Assessment Evaluations
Workbook 4: Process Evaluations
Workbook 5: Cost Evaluations
Workbook 6: Client Satisfaction Evaluations
Workbook 7: Outcome Evaluations
Workbook 8: Economic Evaluations
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Introduction
You should use the appropriate
specialised workbook with this
workbook as you move through the
steps of evaluation implementation.
This workbook describes the general
steps involved in conducting treatment
evaluation, including selecting/prepar-
ing your data collection measure(s),
deciding how to administer the
measure(s), and developing a data col-
lection and management plan. The
workbook then provides advice and
some technical details regarding
analysing and reporting the results.
Some sections should be read by all
evaluation partners, whereas others are
most appropriate for those trained as
researchers and/or functioning as
evaluation consultants. Each section
is marked appropriately.
As the skills and resources that are
available for evaluation vary widely,
you may not be able to undertake all
of the steps and procedures that are
outlined here. However, you should try
to adhere to the basic principles and
steps that are presented. You also
should try to acquire additional re-
sources you may need.
Workbook 1 (on evaluation planning),
and this workbook (on implementa-
tion), will give you foundation tools
and information to plan and imple-
ment programme evaluation. With an
understanding of the material in these
two workbooks, and some practice
applying it, you will be prepared to
undertake evaluations of different
types. The remaining specialised
workbooks in this series present the
principles and practices of these dif-
ferent types of evaluation. You should
use the appropriate specialised work-
book with this workbook as you move
through the steps of evaluation imple-
mentation.
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The six steps of
implementing evaluations
1. Prepare for data collection.
2. Collect data.
3. Analyse data.
4. Report results.
5. Make use of what was learned.
6. Start again.
As described in the framework manual,
there are six steps that you need to
accomplish to implement evaluations:
Each of these steps is presented below. The
discussion of these steps includes some
exercises for you to follow that will help
you learn and apply the material to your
own situation.
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   If you are conducting a...        Then you should review...
Needs Assessment Evaluation Workbook 3
Process Evaluation Workbook 4
Cost Evaluation Workbook 5
Client Satisfaction Evaluation Workbook 6
Outcome Evaluation Workbook 7
Economic Evaluation Workbook 8
Use the foundation and specialised
workbooks together, to help you
make the most of the information
that is presented.
Workbooks 1 and 2 provide a solid foun-
dation of general information about con-
ducting evaluations, whereas the
specialised workbooks (Workbooks 3
through 8) present detailed information for
different types of evaluation. If you already
know what type of evaluation you are go-
ing to conduct, you should consult the
workbook that is applicable. Use the foun-
dation and specialised workbooks to-
gether, to help you make the most of the
information that is presented. If you do
not know what type of evaluation you are
going to conduct, wait until you have de-
veloped your evaluation questions (Step
5) to consult a specialised workbook.
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Step 1
Prepare for
data collection
There are a few important tasks that
need to be accomplished when starting
your study. These include:
1 managing ethical issues
2 developing a data management plan
3 conducting a pilot test
4 writing an evaluation plan.
These tasks are explained in detail below.
1. Manage ethical issues
People being studied need to be protected
from undue burdens on their time, inva-
sion of privacy, and risks or other harms.
You need to pay attention to these ethi-
cal issues!
For all studies involving people as partici-
pants (sometimes called “human subjects”
studies), you must first ask approval from
an ethics committee, and/or consult the
WHO-CIOMS publication, International
Ethical Guidelines for Biomedical Re-
search Involving Human Subjects
(1993). These guidelines are intended to
protect the rights of participants. Some of
the basic principles are outlined below.
Informed Consent.  According to this prin-
ciple, researchers must ask permission of
individuals before enrolling them in the
research study. When you do this, you
The standard practicae is to have a Con-
sent Form that informs clients about
these procedures and that asks for their
written consent for data to be collected
from them or about them. A consent
form typically:
• describes the purposes and methods of
the study explains study requirements,
for example, completion of a question-
naire, the kinds of information re-
quested, the time to complete the
questionnaire, the amount of time in-
volved
No person
should be
forced or
coerced to
participate
in the study.
should explain to them the purpose, na-
ture, and time of their participation. Give
them, or have available upon request, de-
tailed information about the evaluation in
writing. No person should be forced or
coerced to participate in the study.
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• describes the purposes and methods of
the study explains study requirements,
for example, completion of a question-
naire, the kinds of information re-
quested, the time to complete the ques-
tionnaire, the amount of time involved
• explains that participation is voluntary
and individuals can withdraw from the
study at any time without fear of re-
prisal such as withholding of treatment
that the person would otherwise be
entitled to receive
• explains the extent to which confiden-
tiality will be maintained
• explains all foreseeable benefits and
risks that the study poses
• explains any monetary or other benefits (if
applicable) that accompany participation
The investigator must communicate all
necessary information, give the prospec-
tive subject full opportunity to ask ques-
tions, and exclude the possibility of un-
justified deception or intimidation in the
consent process. The participant must
sign the consent form before the infor-
mation is collected, and must receive a
copy of the signed form. If a participant
is illiterate, you must read the consent
form and obtain verbal consent. Note that
consent forms also may be needed for
evaluations that use archival records
about individuals.
Take necessary
precautions to
protect the
safety of your
participants.
Risks of participation
Before beginning a study, researchers
should thoroughly evaluate risks that might
be present for participants. The typical risks
in evaluating treatment programmes for
PSU disorders are accidental disclosure of
the information obtained about patients’
PSU and illegal activities. In addition, evalu-
ations involving biomedical interventions or
confrontational tactics could harm clients
physically or psychologically. Take neces-
sary precautions to protect the safety of
your participants.
Participants may be paid for their inconve-
nience and time spent, and may receive free
medical services in the course of participa-
tion. However, payments should not be so
large, or medical services so extensive, so
that they would induce people to consent to
participate against their better judgement.
Confidentiality
All researchers have an obligation to pro-
tect the confidentiality of their participants.
Researchers must never reveal the name,
address, or any identifying information about
a participant unless they have written per-
mission to do so.  If researchers want to
publish a case report of a participant or a
group of participants, they must change
enough details so that no one could discover
the identity of the person or group.
You should develop procedures to ensure
that all information collected about any
person will remain anonymous.  No names
or other data should be kept that could
identify an individual with the information
gathered. If the data collection plan in-
cludes follow-up with clients over time to
measure services received or individual
outcomes, each client can receive a unique
identification (ID) number. This number
should be the only identifier used in data
processing and analysis. Only authorised
personnel should have access to the names
and other information linked to the ID
numbers for use during the evaluation. In
addition, everyone who collects or pre-
pares data should sign a pledge signifying
they will adhere to all confidentiality pro-
cedures.
You should
develop
procedures to
ensure that all
information
collected about
any person will
remain
anonymous or
confidential.
• uses simple words and concepts that
can be easily understood by partici-
pants
• explains that they are entitled to free
medical care for any harm that results
from participation
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Into action
Our evaluation team discussed all possible
risk that might be present for participants
and how they are going to ensure that all
participant information will remain confi-
dential. They also consulted the WHO-
CIOMS publication, International Ethical
Guidelines for Biomedical Research In-
volving Human Subjects (1993) in order
to write a consent form for their evalua-
tion project.
They created the following consent form:
Our inpatient opiate detoxification programme is conducting a study the
effectiveness of our AIDS education intervention.Participants will complete
a questionnaire at their initial assessment interview at arrival into our
programme. The questionnaires will ask about attitudes, beliefs, HIV-risk
behaviour and psychoactive substance use. Completion of the questionnaires
will take about 15 minutes. Participants are free to skip any questions that
they find troubling or overly personal.
The purpose of this research is to find out if our AIDS education interven-
tion is useful for people with opioid dependence. This information will be
helpful in providing better information on HIV for opioid dependent people.
All questionnaires and information collected from your initial assessment will
be kept confidential; only a code number for each participant will appear on the
questionnaires and initial assessment sheet. All information about clients in this
service will be kept in a safe, locked location. The names of clients will be kept
separate from the information itself.
There is no risk involved in this research, other than the unpleasant feelings
that might arise when thinking about problems associated HIV and your opioid
use. Your drug worker is available to talk to if you experience unpleasant
feelings as a result of participating in this study. There are not likely to be any
direct benefits to participants.
Participation in this research is voluntary. The decision to participate will not
affect the nature of the treatment services participants receive. Your are free to
withdraw from the study at any time without giving any reason and without
prejudice to your continued care.
I understand all the above information, and agree to participate in this study. I
understand that I may withdraw from the study at any time.
Participants Signature Date
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Establish well-defined objectives for your
data collection system, and make a strong
commitment to achieving the objectives.
Your data management plan must also ad-
dress:
• designing your record keeping system
• acquiring and processing the data
• training the people who will collect data
Your evaluation planning group should
consider how to best manage ethical is-
sues in your study. Use the examples pro-
vided below as a guide, then adapt them
to your own evaluation project.
1 Each partner should individually write
down possible safety issues (harm that
could come to your participants) as a
result of participating in your research.
After each partner has finished, you
should discuss these issues as a group.
Write down a specific plan for how you
will minimise or limit this harm.
Example: In a questionnaire survey
study of individuals being treated for
opioid dependence, possible risks in-
clude a) unpleasant feelings that might
arise from thinking about problems as-
sociated with opioid use, and b) pos-
sible breaches of confidentiality.  To
minimise this potential harm: a) all par-
ticipants will be instructed at the time
of enrolling that they may have access
to a trained mental health professional
Its your turn: (1A)
to discuss any unpleasant feelings that
might arise as a result of participation,
and b) use of confidentiality policies and
procedures (see below).
2 Working separately, write down a plan
for how you will ensure that all partici-
pant information will remain confiden-
tial.  Discuss your ideas as a group and
write down a specific plan for how you
will maintain confidentiality.
Example: The data will be kept in a safe,
locked location; the names of participants
will be kept separate from the data itself;
all research staff will sign a pledge of con-
fidentiality.
3 Working as a group, develop a consent
form for participants to sign. This form
should outline the study itself, as well as
all risks of participation. Use the informa-
tion provided in the preceding section and
the example below as a guide. Also con-
sult your institution’s ethical guidelines on
consent of participants, if applicable.
2. Develop a data management plan
Another important step of starting a study
is to develop a data management plan.
Ideally, a programme administrator should
make specific staff responsible for the
important task of data management - col-
lecting and editing the data. Those who
use and interpret the data should under-
stand and appreciate the strengths and
weaknesses of the information collected.
Assignment of clear responsibilities for
data quality is an important part of the pro-
cess.
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Development of
a record
keeping system
or database
design is an
important part
of a successful
evaluation.
Development of a record keeping system
or database design is an important part of
a successful evaluation. The following sug-
gestions may be helpful in guiding you
through this process:
l It is a good idea to delegate one per-
son to monitor the data collection pro-
cess. This person will ideally take
charge of administering the
instrument(s), to make sure that the
data are collected properly, monitor the
forms and questionnaires that are used,
oversee the storage and retrieval of
data, and supervise the data analyses.
l Keep all your records in one place.
This includes any questionnaires, in-
terview schedules, tapes, data collec-
tion forms, and archived materials. By
storing all information associated with
the evaluation in one place you can
avoid problems of having to search
multiple locations to find the informa-
tion you require. Develop a system for
how you will organise the records.
(Organisation by ID number is usually
a good idea.)
l Remember to use ID numbers instead
of names, and to remove any identify-
ing information from the central
records.
l Assign a person (or group of people)
for regular transferral of information on
the records to a central “database.” This
could be a computer file (see below), or
could be a notebook containing ID num-
bers and summary data for each partici-
pant. This transfer of information should
be completed routinely (once a week is
a good guideline).
l Keep the database in a safe location.
Make a “back up” copy if possible, in
case the original data base is damaged
in some way. You can back up com-
puter data onto a separate diskette, or
photocopy written records. Back up
copies should be stored in a separate
location from the central database, in
case of fire, flood, theft, etc.
l Make a habit of routinely picking a few
cases from the database to ensure that
the information in the database corre-
sponds with the information from the
original records (e.g., questionnaires).
This will help to spot errors and/or
make corrections to your data trans-
ferring procedures.
This will require extensive pilot testing to
identify errors and shortcomings that al-
most always exist in the initial stages. It
also requires careful design to make the
best use of limited storage, and to keep
data processing time to a minimum. For
these reasons, it is important to use a
skilled computer programmer to design
and pilot test the database. It is equally
important that the programmer have a
good understanding of what you do, and
what you need from the database.
Database software for microcomput-
ers includes dBASE, Paradox, Rbase,
Dataease, Access and Excel. Becom-
ing proficient with any database soft-
ware requires many hours of use.
Consequently, databases should be de-
veloped only by computer program-
mers with extensive training or expe-
rience with the selected software. A
spreadsheet programme might be a bet-
ter choice for a treatment programme.
Many of the latest spreadsheet pro-
Designing a record keeping system
Designing and setting up an automated
(computer) database
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grams, including LOTUS 123 and Ex-
cel, are easier to use. Database man-
agers are capable of filling most of the
data processing needs you are likely
to have. They have data entry screens
that make them easy to use, and they
can be used for analysis.
If you are using a computer database, you
may want to consider obtaining specialised
software to conduct statistical analyses of
quantitative data. A variety of options are
available, ranging from general programs
capable of performing a wide range of
analyses (SPSS, SAS), to specialised pro-
grams that handle specific types of analy-
ses or provide simple statistical calcula-
tions (Minitab, EPI-Info). EPI-Info is a
specialised piece of software designed for
organising and analysing data from evalu-
ations, surveys and other studies of health
and social services. It is shareware, which
means it is available free of charge. You
may order a copy from: The Division of
Surveillance and Epidemiology, Centres
for Disease Control (CDC) Atlanta, Geor-
gia 30333., USA: Phone 404-728-0545;
Fax 404-315-6440; Internet www.cdc.gov.
If you are using a computer system, each
completed form should be edited for miss-
ing data and other problems before the data
are entered in the computer. Depending
on the number of forms involved and de-
lays due to data problems, this phase can
take up to a month to complete. After in-
formation from a batch of forms is ed-
ited, the data can be entered and processed.
Routine processing should be done every
two weeks, to allow enough data to build
up for efficient operations. Exceptions can
be made when the flow of forms warrants
more or less frequent processing. Auto-
mated procedures for data entry should be
fully explored before the task is delegated
to someone to enter the information into
the computer by hand.
If you are not using a computer, an inde-
pendent person can be assigned to ran-
domly spot check for data entry mistakes
from the original data entry form to the
central data notebook.
Selecting
knowledgeable,
competent data
collection staff
is a key to
success for
high quality
programme
evaluation.
Data collection staff
Selecting knowledgeable, competent data
collection staff is a key to success for high
quality programme evaluation. Your data
collection staff should be trained in rou-
tine or standardised procedures for inter-
viewing and/or administering question-
naires. Training should include an
overview of the purpose of the study, the
purpose of each research measure and how
it is used, and instructions for recording
or filling in responses to each item. The
training should also include some practice
sessions to ensure that the staff members
are comfortable and competent in using
the measures. In addition, the staff should
have a thorough understanding of partici-
pants’ rights to confidentiality, and a plan
for handling unusual or emergency situa-
tions (e.g., suicide attempts, “overdose,”
crises at home or work) that may arise in
the course of data collection.
Data collectors should be trained in the
importance of standardisation of proce-
dures. This means that they should col-
lect data the same way with each partici-
pant. Why? Standardisation helps to ensure
that differences in participants’ responses
are not due to differences in how the data
are collected. For example, if a data col-
lector interviews some participants in a
group situation, but others alone, then
it is possible that differences in responses
are due solely to this different interview
format.
The same principle is true between data
collector: if one data collector is very
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Standardisation
helps to
ensure that
differences in
participants
responses are
not due to
differences in
how the data
are collected.
Into action
friendly to participants, while another is
distant, then participants may give differ-
ent types of responses. Clear training in
standardised procedures helps to prevent
these possibilities.
When considering standardisation, think
about the following issues:
l Will data be collected individually, or
in the presence of others?
l Will participants complete question-
naires on their own, or receive guid-
ance from the data collector?
l How “friendly” should data collectors
be with participants?
l How should data collectors respond to
questions from participants?
There is no right or wrong answer to these
questions: the key to success is ensuring that
everyone does it the same way every time.
This is the essence of standardization.
Data collection also should involve exten-
sive communication between those collect-
ing the data and those managing it. Issues
inevitably arise in the data reporting prac-
tices, and these must be understood by those
using the data. Ideally, select a data co-
ordinator who has enough time to obtain,
edit, and co-ordinate collection procedures,
and who can communicate effectively about
the complexity of your data collection.
Chris C. was selected as the data co-
ordinator. He would supervise the data
collection and will train all other drug
workers at the service in standardised
procedures for administering the ques-
tionnaire. All data would be stored in
locked file cabinets. Chris C. would have
the keys for these cabinets. He would
also collect questionnaire and file them
in a “data to be entered” file within the
cabinet. Once a week, Chris C. would
enter these records into the main record
database using the database software
SPSS. Once every two weeks, Sue R.
would double check Adam’s work to
ensure that errors are not being made.
A separate list, linking data code num-
bers to names, would be stored in the
Sue R. office in a locked file cabinet. She
would be the only one to have the keys
to this file cabinet.
The team decides to conduct a 3 hour-
workshop with all data collector (drug
workers at the service) in order to train
them in standardised procedures of ad-
ministering the questionnaire. This train-
ing would include information about pur-
pose of the study, about the chosen mea-
surements and instructions for filling in
responses to each item as well as some
practice session. Further, the data collec-
tion staff would be informed about the
standardised procedures:
1 The questionnaire will be administered
individually
2 Participants will complete question-
naires by themselves
3 In case of difficulties in completing the
questionnaire the client will receive
guidance from the data collector
4 The data collector should respond to
questions as discussed in the training
workshop
5 The data collector provides time for
questions about the study, after the cli-
ents filled in the questionnaire.
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Its your turn (1B)
Working as a group, complete the follow-
ing tasks:
1 Write down where you will store your
data, how it will be organised to ensure
clarity and protect participants’ confi-
dentiality.
Example: Data will be stored in locked
file cabinets in the main storage area.  Only
the data co-ordinator will have the keys.
A separate list, linking data code numbers
to names, will be stored in the investi-
gator’s office in a locked file cabinet. Only
the investigator will have keys to this file.
2 Write down how you will maintain cen-
tral records of the data, and who will be
responsible for maintaining the records.
Example: A data co-ordinator (Jon)
will collect questionnaires and file them
in a “data to be entered” file within the
cabinet. Once a week, Jon will enter
these records into the main record da-
tabase. Once every two weeks, Serene
will double check Jon’s work to ensure
that errors are not being made.
3 Write down standard procedures for
your data collectors, and a plan for how
you will train them in these procedures.
Example: All data collectors will re-
ceive training in how to obtain consent,
administer the questionnaires in a
standardised fashion, and deal with
emergency situations. Michel (senior
clinician) will conduct this training.  Be-
fore being allowed to collect data, data
collectors will be tested and approved
by the study investigator.
4 If you plan to use clinicians as data col-
lectors, consult with them to ensure that
your data collection plan is feasible from
their perspective. (Because clinicians
sometimes feel too busy to use standard-
ised forms or participate in research,
gaining their co-operation at the outset
is essential.) Work with them to achieve
a mutually agreeable plan.
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3. Conduct a pilot test
(Note: This section is most applicable for
researchers. If you have a researcher
among your evaluation partners, have that
person read this section and then explain
its contents briefly to the others.)
Once you have reached this point, you are
ready to try out your data collection
instrument(s) in a small pilot test. The ba-
sic idea behind conducting a pilot test is
to try out your data collection
instrument(s) in a small, preliminary
sample in order to answer the following
questions:
l Does the data collection instrument pro-
vide useful information? For example, are
variables being measured accurately?
l Can the instrument be administered
properly, given constraints on time and
staff? For example, is the instrument too
long or too complicated to be com-
pleted?
l Can the information be easily man-
aged? For example, can the form(s) be
integrated with the data management
system easily?
l Does other information need to be col-
lected? How did people react to com-
pleting the instrument? What is miss-
ing? How should the questions be
changed, and why?
If a formal pilot test is not possible, have
staff, community members, or patients
complete the draft data collection forms
to see which parts may be unclear, con-
fusing, or otherwise misleading. If a more
formal pilot test is feasible, consider the
following suggestions in testing different
types of forms:
The reason for
a pilot test is
to identify any
flaws in the
data collection
plan so they
can be
corrected
before a full-
blown
implementation
of the
evaluation gets
underway.
1 Self-administered questionnaires:
Select 10-15 people who are similar
to your clients; ask them to complete
the form; and analyse the data. Re-
view the completed forms carefully,
looking for potential problems: Is
there a particular question several
respondents did not answer? Are re-
spondents answering questions they
should have skipped? Are some
checking or circling more than one
response category when instructions
say to give only one answer? If such
problems appear (and they usually
do), talk to some respondents who
failed to answer properly. Ask them
why they answered as they did. The
wording may be unclear, or the for-
mat may need improvement. Using
special type face features might help,
such as italics, underlines, or bold
type for instructions.
2 Interviews: Conduct several pilot in-
terviews to test the interview instru-
ment. Consider having a group discus-
sion with pilot test respondents after
they have completed their individual
interviews. A moderator would lead
the people being interviewed through
the form as a group, encouraging them
to talk about any problems they had
with the questions or the interviewer’s
style, and to suggest changes. Group
discussions can be an effective way to
identify problems and gather sugges-
tions. They also may point out differ-
ences in item interpretation that would
remain hidden in individual interviews.
3 Record Reviews: Pilot testing your
record review forms can be done effi-
ciently as part of staff training for this
activity. Problems in wording or for-
mat should become clear after a few
trials or exercises.
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The reason for a pilot test is to identify
any flaws in the data collection plan so
they can be corrected before a full-
blown implementation of the evaluation
gets underway. Thus, the last step, in
the pilot test phase is to summarise find-
ings and to revise the data collection
plan as needed. If the changes are sig-
nificant, it may be advisable to conduct
another pilot test of the revised proce-
dures before proceeding with the evalu-
ation.
Its your turn (1C)
1 The researcher in the group should ex-
plain the key points of this section to
his/her evaluation partners. For ex-
ample, explain the important functions
that pilot tests serve, and how to con-
duct them properly.
2 As a group, write down when you will
conduct a pilot test, and how many
people will participate in each portion
of it. Use the information in the pre-
ceding section as a guideline for choos-
ing the number and type of people for
your pilot test.
You may want to have a staff meeting to
introduce the evaluation and the data col-
lection plans to everyone else who will be
involved. This meeting would explain the
reasons for the evaluation, the questions
to be addressed, and the importance of each
person’s role in answering the questions.
After you have pilot-tested your data col-
lection instrument and have incorporated
any changes that are needed, you are ready
to formally start collecting data.
Into action
The next task was to conduct a pilot test.
Each of the drug workers administered
the baseline questionnaire to two clients.
Afterwards the collectors and the evalu-
ation team discussed identified flaws.
The data collectors reported that given
the emotional and physical state of some
clients, it seemed not wise to administer
the questionnaire at the first face- to-
face interview with the client. They sug-
gested that the questionnaire should be
given to the client during the second day
of his stay at the unit during his second
individual contact with his drug worker.
The evaluation team agreed to adminis-
ter the questionnaire during the sug-
gested second interview with the drug
workers. Apart from some wording
problems, no other difficulties arose
from administering the questionnaire. To
administer the questionnaire took on
average 15 minutes.
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4. Write an evaluation plan
The final step in preparing for data col-
lection involves the preparation of a writ-
ten evaluation plan. Writing a structured
evaluation plan will help you to organize
your thoughts clearly. It also serves as a
reminder to everyone involved about the
purpose of the evaluation and what ques-
tions and decisions the results are in-
tended to address.
The basic elements of an evaluation
plan are:
1 Background and General Purpose
This is a summary of your evaluation
plan. It should include a brief descrip-
tion of the purpose of the evaluation,
how you plan to conduct the evalua-
tion, who will receive the results, and
how results will be used.
2 Programme Logic Model  (refer to
Step 4 of Workbook 1 for more infor-
mation). The model should describe:
l   what it is that you plan to evaluate (e.g.
services, network of services);
l   your process or implementation ob-
jectives — the short-term and long-
term goals of various parts of your
programme/service/system.
3 Evaluation Team
This section lists the people who will
be involved with your evaluation
project, along with a brief description
of their experience and anticipated roles
in the evaluation.
4 Evaluation Questions to be addressed
Your questions should follow logically
from your programme logic model and
should be linked to one of your
programme’s implementation objec-
tives or goals in a specific way.
5 Data Collection Strategy
This section is very important, as it
explains how you will get from your
evaluation questions to results. Re-
fer to Steps 6 and 7 of Workbook 1
for information and suggestions about
creating your data collection strategy.
For each evaluation question you listed
above, you should indicate:
l   whether you will use a standardized
data collection or develop your own,
and what the specific variables you
plan to use are how you will collect
the data;
l   who will administer the data collection
instrument(s);
l   how many participants you will as-
sess-your sampling strategy (how you
will choose participants)-your time line
for data collection.
6 Data Management Plan (refer to
Step 1-B of Workbook 2 for more
information)
In this section, explain how you will
store your data and maintain central
records.
7 Staff Training (refer to Step 1-B of
Workbook 2 for more information)
Describe how you will train all evalua-
tion staff to conduct their jobs in a  stan-
dardized way, and whether additional
staff or outside consultants will be
needed.
8 Pilot Test  (refer to Step 1-C of Work-
book 2 for more information)
What type of pilot test will you con-
duct, and how many people will par-
ticipate in each portion of it? If you
are using a newly developed data
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Its your turn (1D)
1 Compose a written evaluation plan.
Use the exercises that you have com-
pleted so far to help you. Components
should include:
l Background and general purpose of the
evaluation (Step 3, Workbook 1)
l Programme logic model (Step 4,
Workbook 1)
l Evaluation questions to be addressed
(Step 5, Workbook 1)
l Data collection strategy (Steps 6 and
7, Workbook 1)
l Data management plan (Step 1B,
Workbook 2)
l Staff training (Step 1B, Workbook 2)
l Pilot plan (Step 1C, Workbook 2)
l Strategy for using results
collection instrument, you should in-
clude it in your pilot test and then
make changes as necessary after the
pilot test.
9 Strategy for Using Results
Explain how your evaluation results can
be applied to the long-term goal of im-
proving substance use treatment. Ex-
plain who will receive results, and how
this information could be used to make
changes to improve treatment.
2 Review your written evaluation plan
with the expected user(s) of the results.
Modify as needed.
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Step 2
In resolving data
collection
problems, keep
the instruments
and procedures
consistent
unless you must
make changes
to solve fatal
flaws in the
project.
(Note: This step is most applicable for re-
searchers. If you have a researcher among
your evaluation partners, have that per-
son read this section and then explain its
contents briefly to the others.)
Collect data
If you have planned carefully during the
preceding stages, data collection should
proceed smoothly and with little need for
readjustment.  Nonetheless, a few guide-
lines may assist you:
 Periodic meetings with staff involved in
the data collection can be very helpful.  The
topics can include questions about data
collection. Write down how these ques-
tions are resolved.  You also may need to
discuss results of reliability and validity
checks on the indicators, and preliminary
findings.
 In resolving data collection problems,
keep the instruments and procedures
consistent unless you must make changes
to solve fatal flaws in the project.   Even
minor changes in forms and procedures
can cause more problems than they
solve.  For this reason, once you have
started your data collection, attempt to
make it as systematic and as free from
bias as possible.
Over time, data collectors’ skills tend
to erode. Periodic retraining of data col-
lectors, even every few months, can
help ensure quality control during your
study.
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Into action
Our evaluation team decided to meet twice
a month to discuss problems with data
collection and entry. Sue will be respon-
sible for organising them. She will also take
responsibility for recording the decisions
about the evaluation project.
Its your turn
The researcher in the group should make
the following decisions:
1 Write down how often you will have
research team meetings, and who will
be responsible for organising them.
2 Nominate a person to take responsi-
bility for recording the decisions
about research procedures. Have this
person maintain a notebook of all
these decisions, so they can be re-
ferred to later if questions arise.
Discuss your plan with your evaluation
partners. Make changes based on their in-
put as appropriate.
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Step 3
Analyse data
(Note: This step describes technical infor-
mation about data analysis procedures. It
is most applicable for researchers and or
data consultants. If you have a researcher
among your evaluation partners, have that
person read this step and then explain its
contents briefly to the others.)
Data analysis is the reward for all of your
planning and data collection efforts. If you
carefully plan and carry out data collec-
tion, the analyses will help you provide
answers to questions about what efforts
your programme is making and what ef-
fects those efforts are having.
Data analysis is not simple, and requires cal-
culation, interpretation, and judgement. Do
not hesitate to obtain technical assistance,
if available, during this phase of the evalua-
tion.
A general guideline is that the methods
of analysis you choose should be tai-
lored to the specific evaluation ques-
tions with which you started. These
choices also depend on the size of the
sample you collect, the quality of the
data, the resources available to you
(e.g., transcribers, interpreters, comput-
ers with statistical programs installed),
and the effort you are willing to put into
the analysis. This section will introduce
you to a number of general concepts and
procedures in data analysis and presen-
tation.
Decide whether you are addressing
descriptive or explanatory questions
Before you begin your analysis, it is very
important to be clear about what general
type of analysis you wish to conduct.
Descriptive analysis summarises the
measurements you have made on the vari-
ables included in the data collection in-
Descriptive
analysis
summarises the
measurements
you have made
on the variables
included in the
data collection
instrument.
Explanatory
analysis
attempts to
explain
relationships
among the
variables in
which you are
interested.
strument. Explanatory analysis attempts
to explain relationships among the vari-
ables in which you are interested.   The
figure below summarises the differences
between these two different approaches
to data analysis.
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As the figure shows, descriptive analyses
summarise the data collected for each indi-
vidual variable. If your indicators are quan-
titative in nature, descriptive analyses can
be used to provide information for ques-
tions such as “how many clients in the
programme are over the age of 50?”, or
“how much time did staff spend complet-
ing administrative forms in the assessment
process?”, or “how much variability was
there in the education levels of our clients?”.
If your indicators are qualitative in nature,
descriptive analyses can be used to provide
information for questions such as: “what
types of responses were reported when cli-
ents were asked about the most beneficial
aspect of the programme?”
The figure also shows that explanatory
analyses describe relationships between
or among variables included in your data
collection instrument(s). Explanatory
analyses can also use either quantitative
or qualitative data. For example, if your
indicators are quantitative in nature, ex-
planatory analyses can be used to pro-
vide information for questions such as
“do male and female clients differ in their
relapse rates in our programme”, or
“compared to clients who didn’t receive
a motivational interview, were clients in
the interview programme more likely to
show up for group therapy sessions?”.
If your indicators are qualitative in na-
ture, explanatory analyses can be used
to address questions such as “did clients
who reported liking the harm reduction
orientation of our programme report
more positive benefits in our inter-
view?”.
Descriptive analysis
Goal:
Explanatory analysis
to summarize the mea-
surements for each vari-
able
Goal: to explain relationships
between variables and
groups
Examples: How many clients re-
ported?
How much time did
staff spend?
How much variability
was there in ...?
Examples: Do male and female cli-
ents differ?
Compared to clients as-
signed to a control
group. were clients ex-
posed to ... more likely
to...?
Different types of data analysis
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1 Has the number of referrals increased
from the previous year?
2 Did the characteristics of the clients
change in comparison to last years cli-
ents?
3 Has the number of self-discharges de-
creased from the previous year?
4 Has the number of clients who were re-
ferred to long-term treatment increased
from the previous year?
Descriptive analysis with quantitative
indicators
Descriptive analysis with quantitative
indicators
Descriptive analysis with quantitative
indicators
Descriptive analysis with quantitative
indicators
DescriptionQuestions
Into action
The research questions regarding the process evaluation would be analysed with the
following types of analyses
Descriptive analysis with quantitative
indicators
Descriptive analysis with quantitative
indicators
Descriptive analysis with quantitative
indicators
Descriptive analysis with quantitative
indicators
DescriptionQuestions
5 Did attitudes in favour of HIV low-risk
practices improve among clients?
6 Did client’s HIV-risk behaviour change
in favour of low risk practices after
treatment?
7 Did clients knowledge about AIDS in-
creased after the AIDS education inter-
vention?
8 Did clients self-efficacy regarding their
ability to use skills maintaining AIDS
harm reduction behaviours increase?
For the outcome evaluation they decide on the following analyses:
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1 Write down 4 research questions re-
lated to your evaluation project.
2  Decide what type of analysis (or analy-
ses) you will conduct for each ques-
tion:
Descriptive analysis with quantitative
indicators (Section A)
Its your turn
Descriptive analysis with qualitative in-
dicators (Section B)
Explanatory analysis with quantitative
or qualitative indicators (Section C)
3 Review the appropriate sections below.
Recall from Workbook 1 that quantitative
indicators can be arranged into different
types, based on the measurement scale
that they use (nominal, ordinal, interval,
ratio). Each type of scale can be analysed
in different ways, and lend itself to differ-
ent presentation strategies, as indicated in
A. Descriptive analysis with
quantitative indicators
the following subsections. The subsections
below (frequencies, measures of central
tendency, measures of variability) provide
information on how to calculate statistics
that summarise the variables in your evalu-
ation.
If you count
how many
observations
fall into each
category, you
obtain a
statistic known
as a frequency.
Frequencies1
Simple frequency tables are used to see
patterns in groups of nominal and ordi-
nal data. A frequency distribution pro-
vides a record of the number of indi-
viduals located in each category of the
quantitative indicator. If you count
how many observations fall into each
category, you obtain a statistic known
as a frequency. If you know the total
number of observations that were mea-
sured for that variable, you can calcu-
late the percentage of observations in
each category by simply dividing the
number of cases in each category by the
total number.
A frequency table displays these results.
As the next figure shows, a frequency table
lists the number of observations in each
category.  The table also presents the total
number of cases and the percentages.
In the example presented on the next
page, measurements have been taken to
assess severity of PSU problems for 125
hypothetical clients.
1
 Note that all of the
major statistical
packages for
computer-aided data
analysis have routines
that will calculate
frequencies
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Title: PSU problem severity for a
Sample of 125 hypothetical clients
Labels
Totals
Category Frequency Percentage
None reported
Mild
Moderate
Severe
Very severe
42
13
50
15
5
125
33.6
10.4
40.0
12.0
4.0
100.0
In some cases, especially with small sample
sizes, you might want to show the fre-
quency of every measurement value.  In
most cases, however, (and especially for
interval and ratio data) you will want to
group these measurements into a smaller
number of categories called a grouped
frequency table.  The next figure shows
an example, this time using client age as
the variable.
Age (years) Frequency Percentage
5
5
20
30
60
160
3.1
3.1
12.5
18.8
37.5
60-69
30-39
20-29
Totals
40 25.010-19
A grouped frequency table describing age of clients
100.0
50-59
40-49
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Measure Definition Data-types Examples
Score which
occurs most
Moderate
Average
Nominal
Ordinal
Mode
Median
Mean
Ordinal
Interval
Gender
Client Satisfaction
Client Satisfaction
Numbers of
Counseling
Each grouping is called an interval, and
the number of scale values in each in-
terval is called the interval width.
There are no strict rules for deciding
on the number of intervals or their
width.  But in general, there should not
be so many groupings that you end up
with only one or two observations in
each group. On the other hand, there
should not be so few groupings that the
highest and lowest observations are not
distinct from each other.  For conve-
nience, the interval width should be a
whole number.
Measures of central tendency
Another useful way to summarise the mea-
surements you have made for a variable is
to report the average or typical measure-
ment in your data for that variable. We
call this the data set’s central tendency.
There are three ways to describe central
tendency: mode, median, mean. These are
shown in the next figure.
Measures, definitions, data types, and example of central tendency
The mode is
the score that
occurs most
frequently.
The mode is the score that occurs most fre-
quently. This measure of central tendency
can be used for nominal, ordinal, or inter-
val scale data. Not that a data set can have
more than one mode if the maximum fre-
quency occurs equally for two or more ob-
servations for a variable.
The median score is the one that separates
the upper half of the observations from the
lower half of the observations. In other
words, 50% of the scores fall above the
median, and 50% of the scores fall below
the median. To calculate a median, you must
be able to rank order the scores from high-
est to lowest. This measure of central ten-
dency can be used with both ordinal and
interval scale data. One important property
of the median is that, unlike the mean, ex-
treme scores do not affect it.
The mean is the arithmetic average for the
observations on that variable.  It is the
measure of central tendency that is used
most often to describe a set of interval-
scale observations.  To calculate the mean
The median
score is the one
that separates
the upper half of
the observations
from the lower
half of the
observations.
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for a variable, simply add up all of the
scores and divide that sum by the total
number of scores. The next figure
summarises these measures of central ten-
dency, using a hypothetical example of 11
observations made on a client satisfaction
variable, which uses a 5-point interval
scale. A mean score can be influenced sig-
nificantly by one or two extreme scores in
the set of observations.
The mean is the arithmetic average for the
observations on that variable. It is the mea-
sure of central tendency that is used most
often to describe a set of interval-scale
observations. To calculate the mean for a
variable, simply add up all of the scores
and divide that sum by the total number of
scores. The next figure summarises these
measures of central tendency, using a hy-
pothetical example of 11 observations
made on a client satisfaction variable,
which uses a 5-point interval scale. A mean
score can be influenced significantly by one
or two extreme scores in the set of obser-
vations.
The mean is the
arithmetic
average for the
observations on
that variable.
Client satisfaction data
(5 point interval scale)
Rank-ordered
data
5
4
4
3
2
1
5
1
1
2
3
1
24
5
4
4
3
5
1
1
2
Note: 1=hated program; 2=disliked program; 3=neutral; 4=liked program; 5=loved program
Mean
Median
Mode
=
=
=
Sum of scores
# of scores
2
1
(divides observations into upper & lower halves)
(most frequently occuring observation)
24
11
= 2.18=
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A measure of central tendency is not enough
to summarise or describe a quantitative vari-
able. You also need to know how widely a
set of observations varies around its aver-
age. Another way to think about variability
is that measures of variability provide a
useful summary of how different the ob-
servations are from each other. There are
several measures that can be calculated.
The range determines the extreme obser-
vations in your data set and the difference
between them. For example, a series of
observations made on a 5-point client sat-
isfaction interval scale might look like this:
2, 1, 4, 3, 3. The range of scores here is 1-
4 (lowest observation to highest observa-
tion). The range is useful because it tells
us about minimum and maximum obser-
vations for a variable. Unfortunately, it
only tells us about extreme scores and
doesn’t take into account all of the obser-
vations at once.
The standard deviation describes how far
the observations deviate from the mean
in a data set. It is the most important and
most widely used measure of variability.
It is always reported in conjunction with
the mean for a variable (e.g., “mean cli-
ent satisfaction in the sample was 3.2,
with a standard deviation of 1.7”). How
do we calculate a standard deviation?
There are two important properties of this
measure:
l if all of the observations are equal to
the mean, then there is no variability in the
observations;
l the more the observations differ from each
other, the greater the standard deviation for
that variable.
To calculate standard deviations, we need
to introduce the concept of deviation
scores. Here is the way we represent de-
viation scores:
X - µ,
where any single observation (X) is sub-
tracted from the overall mean of the ob-
servations for that variable (µ). To calcu-
late a standard deviation, we first have to
square the summed deviation scores for all
observations:
sum (X - µ)2 = SS = sum of squares
This value is called the “sum of squares” be-
cause it simply reflects the sum of the squared
deviation scores for our data.
The variance of our variable gives us an “av-
erage” of the variability of our observations,
and is calculated as follows:
S2 = variance = SS (sum of squares)/N
where N = the number of observations in
our data set for that variable.
Finally, the standard deviation of our
variable is simply the square root of the
variance:
S = standard deviation = square root of
variance
You can see on the next page an example,
again using client satisfaction data, but this
time for only 7 observations:
Measures of variability2
The range
determines
the most
extreme
observations
in your data
set and the
difference
between
them.
The standard
deviation
describes
how far the
observations
deviate from
the mean in a
data set.
2
 All of the major
statistical packages
for computer-aided
data analysis have
routines that will
calculate measures of
variability for you
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X
(Observations)
X - µ
(Deviation Scores)
(X - µ)2
(Squared deviation scores)
-1
-1
0
0
0
1
1
1
0
0
0
1
3
3
4
4
4
5
1 15
         sum = 28                       sum = 0                              sum = 4 = sum of
             squares
         mean = 28/7 = 4 = µ
         Variance = SS/N = 4/7 = .57
         Standard deviation = square root (.57) = .76
Remember the following steps when cal-
culating standard deviations:
l Calculate the mean for the variable;
l Subtract the mean from each score; put
these values in a separate column;
l Square each deviation score; put these
values in a separate column;
l Calculate the variance and standard
deviation, after summing the columns.
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B. Descriptive analysis with
qualitative indicators
Decide whether
your analysis will
try to find
examples of
what interests
you already.
This is referred
to as a top-down,
deductive
method. Your
alternative will
be to construct
types based on
what you find.
This is a bottom-
up, inductive
method.
Whenever you have qualitative (detailed
observation-based or language-based) in-
dicators in your data set, instead of statis-
tics, descriptive analyses provide a series
of responses that summarise the indicators
and describe their characteristics.
Several preliminary steps are required to
conduct descriptive analyses of qualitative
data. The steps include the requirements:
l Make sure that each of the indicators
has received an accurate transcrip-
tion. In other words, you must trans-
fer taped interviews to computer files
containing the qualitative information.
Further, checks should be made in or-
der to ensure that whoever was del-
egated to transcribe interviews accu-
rately recorded the information. If you
are using open-ended written descrip-
tions, transfer them to computer files
so that they can be easily sorted and
manipulated.
l Make sure that you have allocated suffi-
cient time and staff resources to con-
duct the descriptive analyses of the quali-
tative data. Descriptive analyses of
quantitative data, can be accomplished
easily using widely-available computer
programs. However, qualitative analyses
require people to interpret the indicator.
This takes extensive time and effort. Do not
undertake these analyses unless you are pre-
pared to devote the resources to them.
l Decide whether your analysis will try
to find examples of what interests you
already. This is referred to as a top-
down, deductive method. Your alter-
native will be to construct types based
on what you find. This is a bottom-
up, inductive method.
One prominent approach to descriptive
qualitative analysis is to use the tran-
scripts to find examples of types that
already interest you. Consider, again,
the variable used earlier in this workbook
to illustrate qualitative data: “of the pro-
gramme most liked.” You might approach
this qualitative analysis in a top-down
manner if you have preconceived ideas
about the types of responses that might
be given (e.g., if you think, in advance,
that clients will report that three aspects
of the programme are most liked: (1)
harm reduction philosophy, (2) staff (such
as case therapists), and (3) follow-up sup-
port groups. If you adopted this ap-
proach, the following steps could be fol-
lowed:
l assign a reader who reviews and inter-
prets each of the observations
l instruct the reader to read through the
transcripts three times. The first read-
ing will identify all responses that men-
tion the harm reduction philosophy. The
second reading will identify all responses
that mention staff, and the third reading
will identify all responses that mention
the follow-up support groups
 l After each reading, the interpreter collects
the responses for each type and collates
them into one document. The result will
be three documents: one describing all
of the interview responses for each type
of interest to the programme evaluator
(harm reduction, staff, follow-up groups)
l A second reader will duplicate the first
reader’s interpretations, in order to de-
termine whether instances of the three
types were missing
Top-down (deductive) analysis
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Another approach to describing qualita-
tive data is used when you don’t have a
preconceived idea of the types of responses
that are given when the indicator is used.
This approach attempts to describe the
Bottom-up (inductive) analysis
variety of responses that are given. Your
goal is to develop the types from the infor-
mation you have, rather than confirm or
disconfirm their existence. The figure on
the next page provides an example:
This figure presents a rudimentary
analysis of three clients’ responses to
the open-ended qualitative question.
In the bottom-up approach, the reader
or interpreter attempts to develop a
record of the types expressed in the
observations. In this example, two
main types were reported:  group
therapy (by clients 43 & 89) and forms
(by client 112). Note that within the
group therapy type, the interpreter
identified three different types. These
subtypes reflect different aspects of
group therapy that were viewed posi-
tively; the fact that it gave good in-
formation (client 43), the flexibility of
goals (client 89), and support from
other clients (client 43). As you can
see, the inductive approach yields new
types of responses, as opposed to
finding examples of  pre-exist ing
types.
In general, it is better to use both induc-
tive and deductive approaches to control
for one another. The following guidelines
should be kept in mind:
l The interpreter must systematically read
all of the transcripts, not just interest-
ing ones or ones that show the data in
a particular light.
l The interpreter must systematically docu-
ment the analysis by recording where
the examples can be found, and what
aspects of the transcript support the in-
terpretation.
 l The interpreter’s work should be
checked by another reader, who
doesn’t know the results of the first
analysis. This will allow you to deter-
mine whether there are any biases in
the interpretative process.
Indicator
Observations
Types
What is the aspect of the programme you liked
best?
For me, it has to be the amount of good information I got
and the support from other members of the group (Client
#43)
I liked the fact that I could set my own goals regarding
drinking and work in group therapy to achieve them. (Client
#89)
I didnt have to fill out too many forms (Client #112)
group therapy [43, 89] + group therapy (information) [43]
+ group therapy (own goals) [89]
+ group therapy (other clients) [43]
forms [112]
(Hypothetical Data)
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C. Explanatory analysis with
quantitative or qualitative indicators
Descriptive analyses cannot fully answer
all types of questions, such as: Do clients
abusing alcohol and cocaine differ in the
number of times they have been arrested
for PS-related problems; or compared to
clients assigned to a comparison group,
were clients who received a motivational
interview more likely to attend group
therapy sessions? To make these determi-
nations, you need to go beyond simply
describing the frequencies, central ten-
dency, and variability of the variables you
collected in your programme evaluation.
Inferential statistics go further to exam-
ine relationships among variables in your
evaluation. The following subsections out-
line two of the basic inferential techniques
that are available for you. However, there
are many more techniques that can be used,
and you should seek technical help, if avail-
able, to conduct more advanced types of
explanatory analysis.
The X2 test is based on the idea of find-
ing the difference between the observed
frequencies, displayed in the figure, and
the frequencies that you’d expect, if the
two variables are independent of each
other.
Chi-square (X2) test
The 2 test is a technique that can be used
to test the strength of the relationship
between two variables. This test is used
with nominal data (e.g., gender, types of
programmes), but also can be used with
ordinal or grouped interval data. For ex-
ample, you might want to compare the
proportion of clients who relapsed fol-
lowing motivational interviewing with the
proportion of clients who relapsed in your
comparison group who received no mo-
tivational interviewing.
To begin, cross-classify each observa-
tion across the two variables: e.g., mo-
tivational interviewing versus no moti-
vational interviewing, and relapse ver-
sus no relapse. Then, count the num-
ber of observations that fall into each
of the categories created. For example,
maybe you have a total of 200 obser-
vations (clients): 100 received motiva-
tional interviewing and 100 did not.
Within the “motivation group,” 68 did
not relapse, while 32 did relapse. Within
the no-intervention group, perhaps 45
did not relapse while 55 did relapse.
You can arrange this information in a
contingency table, as shown in the fig-
ure below.
Motivational
interview
No interview
Column
Totals
X2 Test of association between two variables
 68                32                100
 68                32      100
Observed frequencies
Didnt relapse Relapsed (Row totals)
 45                55      100
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Here is how to calculate the expected values of the frequencies for each cell:
Now that we have calculated the ex-
pected values, we will test whether or
not these expected frequencies differ
from the actual, observed frequencies in
our data.
The chi-square (X2) statistic provides
a way for us to compare the actual
and expected frequencies, and is cal-
culated as:
X2 = sum (of - f
e
)2/f
e
,  where
of = observed  frequencies,
and f
e
 = expected frequencies
If there is very little difference between our
observed and expected frequencies,  X2
will be a small value.  If there is a great
difference between our observed and ex-
pected frequencies chi-square will be a
large value.
Hence, our observed value of  X2 = 10.76.
Our question is now: is this observed value
of chi-square sufficiently large to reject the
hypothesis that motivational interviewing
and relapse are independent?  If there is
no association between the two variables,
what is the probability of obtaining an X2
value this large just by chance? Remem-
ber, motivational interviewing may not be
associated with decreased relapse rates. If
this is so, you may have happened by
chance to test a sample of clients for whom
this is true.
To answer these questions, you must con-
sult a table of critical values for the X2
statistic. This table reports the likelihood
of obtaining various  X2 values by chance
alone.  Any statistical textbook (see refer-
ences) will provide a table of critical val-
ues. To use the table, you need to know
the appropriate “degrees of freedom” and
Category of fe (of - fe) (of - fe)2 (of - fe)2/fe
Interview/no relapse 45 56.5 -11.5 132.25     2.34
Interview/relapse 55 43.5  11.5 132.25     3.04
No interview/no 68 56.5 -11.5 132.25     2.34
No interview/relapse 32 43.5  11.5 132.25     3.04
sum (of - fe)2/fe    = 10.76
f
e 
(expected value for the cell) = (row total) X (column total)/N
Therefore,
f
e
(interview + no relapse cell) = (100)(113)/200 = 56.5
f
e
 (interview + relapse cell) = (100)(87)/200 = 43.5
f
e
 (no interview + no relapse cell) = (100)(113)/200 = 56.5
f
e
 (no interview + relapse cell) = (100)(87)/200 = 43.5
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“level of significance”.  Most of the time,
a level of significance of .05 is set, which
declares that the difference between the
groups is probably real if the likelihood of
obtaining an  X2 that large by chance is
less than 5 percent.  With two variables, a
one degree of freedom test is indicated.
At the .05 level of significance with one
degree of freedom, the critical value of
Independent samples t-test
The t-test is used to test whether two
independent* groups have truly different
mean scores on some variable of inter-
est. For example, you might want to
know whether methadone clients who
receive take home privileges use heroin
fewer days per month than clients who
do not have these privileges.
The t-test examines the difference be-
tween the two group means on a vari-
able. It takes into account the variabil-
ity of the scores and the number of
observations in each group. A test sta-
tistic is computed (>t’) that shows
whether the difference in the means
across the groups reflects a true differ-
ence or random fluctuations. As in the
chi-square statistic, a large t value indi-
cates that the groups are quite different
from each other (e.g., if you repeated
the evaluation again, you’d find the same
difference between the two groups). A
small t value indicates that the difference
between the means is likely due to
chance.
* The values of the observations in one group are
independent of the values of the observations in
the second group. For example, we may be com-
paring a group of clients treated with behavioural
therapy vs. drug therapy. These two groups are
clearly different from each other. There are differ-
X2 is 3.84. That is, any observed  X2 value
greater than 3.84 would be considered sta-
tistically significant, while any observed
value below 3.84 would be considered
chance.  In the present example, since the
observed value of  X2 is 10.76, we con-
clude that there is a statistically significant
relationship between motivational inter-
viewing and relapse rates.
A conceptual formula for t is as follows:
t = (mean for group 1 - mean for group
2)/(standard error)
or …
As you can see, if the numerator of this
equation is zero, the overall value of t will
be zero, indicating that there are no dif-
ferences between the groups.  But if the
difference is large, relative to the variabil-
ity within the groups (the standard error),
then t will also be large, suggesting that
there is a true difference between the group
means.
The following example presents data on
the number of abstinent days reported
during a 20 day methadone treatment
programme, for two different client groups
(there were 9 clients in each group):
ent types of  t-tests for situations where the groups
are not independent (e.g., when making compari-
sons for the same group of clients at  two different
points in time). Consult a statistical text and/or a
research professional to decide whar types of test
are appropriate for your evaluation question(s).
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Group 1 Group 2
(clients without privileges) (clients with privileges)
13 11
13   9
10 12
14 10
14 14
10   7
12   9
12 10
10  8
—- —-
Means: 12 10
Standard
deviations: 1.66 2.12
The question becomes: Are the mean num-
ber of abstinent days reported in the two
groups significantly different from each
other?  (Or, are clients with privileges ac-
tually more abstinent than clients without
privileges?).
This formula can be expanded as follows:
= (12 - 10)/[(8 X (2.76) + 8 X (4.49))/16]
X [1/9 + 1/9] =  2.23
Our observed value of t = 2.23. Our
question is now: is this observed t value
sufficiently large to reject the hypoth-
esis that there is no difference in the
number of abstinent days between the
two groups? If there is no difference
between the two groups, what is the
probability of obtaining a t value this
large just by chance?
To answer these questions, you must again
consult a table of critical values for the t
statistic, which reports the likelihood of
obtaining various t values by chance alone.
Any statistical textbook (see references)
will provide a table of critical values. As
in the case of chi-square, you need to
know the appropriate degrees of freedom
and level of significance. Most of the
time, a level of significance of .05 is used,
which declares that the difference between
the groups is probably real if the likeli-
hood of obtaining a t that large by chance
is less than 5 percent.  In the present ex-
ample, the degrees of freedom are 16 (see
a statistical text to determine degrees of
freedom for a t-test). At the .05 level of
significance with 16 degrees of freedom,
the critical value of t is 2.12. That is, any
observed t value greater than 2.12 would
be considered statistically significant,
while any observed value below 2.12
would be considered chance. In the
present example, since the observed value
of t is 2.23, we conclude that there is a
statistically significant difference in the
number of abstinent days reported by the
two client groups.
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Into action
After describing the type of analysis for
each research question, Adam S. gave a
brief overview about the most appropri-
ate data analysis for each evaluation (pro-
cess and outcome evaluation).
Process evaluation
For research question investigating the
service coverage at the activity level num-
ber of clients would be calculated and com-
pared to last years figure.
Outcome evaluation
Data analyses procedures for the outcome
evaluation were proposed as follows:
In order to compare pre- and post-inter-
vention knowledge about AIDS, degree
of engaging in high risk behaviours and
attitudes towards AIDS a t-test for de-
pendent samples would be carried out,
because variables taken into account
were all measured at an interval scale.
The level of significance of .05 would
be used, which declared an observed dif-
ference between pre- and post-interven-
tion could have arisen by chance in 5%
of cases.
Its your turn (3C)
1. The partner who read this section should
briefly describe the most appropriate data
analysis procedures to his/her evaluation
partners. Remember, this is highly techni-
cal information, so a brief overview is all
that is needed for your partners.
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Step 4
Report results
Your evaluation is not complete until the
results are communicated to the user(s)
of the research. You can present the re-
sults in writing, with pictures or graphs,
or in oral presentations.
If your results are favourable to your cur-
rent programme or treatment network,
then you should plan carefully for how you
will present them, in order to maximise
their impact. On the other hand, if your
results indicate that your programme is not
performing as expected or desired, then
you have an opportunity and a challenge.
You can decide what changes are needed
in your programme, then present the re-
sults with the proposed changes at the
same time.
A detailed, written report of the evalua-
tion is a good place to start. This report
can be distributed within your evaluation
team, and/or to the users of the results.
Components should include:
Title page
The title page should include the name
of the report, the name and address of
the programme, the time period of the
evaluation, and the date the report was
completed.
Summary
The summary is very important because
many people do not have time to read the
full report and may read this only. Sum-
maries are usually 1-2 pages long, and
contain the purpose of the evaluation, a
very brief description of the programme,
how the evaluation was conducted, impor-
tant results and conclusions, and recom-
mendations.
Table of contents
The table of contents will help readers to
find information quickly.
Description of programme
This section should briefly describe the
programme that was evaluated.
Evaluation questions
Start by presenting your evaluation ques-
tions to the reader.
Written report
(Note: This section
should be reviewed by
all evaluation
partners.)
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Description of evaluation
This section explains the methods used
for the evaluation.  It should describe who
conducted the evaluation, and where, and
what measures were used to collect data.
Results
This section presents the results of the data
analysis.
Conclusions and
recommendations
This section is very important, because it
is where you can make recommendations
about what to do in response to the evalu-
ation findings.
Oral report
If you are presenting information orally, it
is important to remember that the average
listener will retain only 3 or 4 main mes-
sages from your presentation.  Be selec-
tive.  Use visual aids to help orient listen-
ers and keep their attention. Keep visual
aids simple and to the point.
Think about highlighting certain results
for different audiences. For example, ad-
ministrators may want to know about ef-
ficiency or cost issues, while clinicians
may be interested in hearing about the
views of patients. Some audiences may
be familiar with your programme, while
others will not be familiar, and will need
background information about your
organisation. In each case, it is impor-
tant to tailor your presentation to your
audience.
Consider giving oral presentations (and
making written presentations available) in
the following settings:
l A programme staff meeting
l A board meeting
l A meeting for funder(s)
l A meeting for patients/clients
Visual aids
Bar graphs and pie charts are useful for
summarising data in written and oral reports.
A good bar graph has the following features:
l Both the categories and the frequency
labels are clearly indicated.
l The length of each bar in the graph
shows the frequency for that particular
category
l The corresponding percentage of ob-
servations are presented at the top of
each bar in the graph.
l All of the bars are of the same width.
l Adjacent bars are separated by a space.
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These same data can be displayed in a pie chart:
Grouped frequency data can be presented
in two ways: histograms and line graphs.
Histograms are like ordinary bar graphs,
except that they (a) use interval-scale data,
and (b) the data are grouped in intervals.
An alternative to the histogram is a line
graph.  Instead of drawing a bar for each
interval, put a point above the centre of
each interval marker and connect the ad-
jacent points by straight lines.
Preparation
40%
Contemplation
33.6%
Contemplation
10.4%
Maintenance
4%
Action
12%
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Its your turn (4)
1 Among your partners, nominate a per-
son to take responsibility for preparing
the written report. Use the format de-
scribed above to create it.
2 Nominate another person to take re-
sponsibility for preparing oral report(s).
Remember to tailor your reports to the
intended audience.  If you have mul-
tiple audiences, you may want to as-
sign different people to prepare differ-
ent reports:
• Funder(s)
• Expected users of the research
• Clinicians
• Patients
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Step 5
Make use of what
was learned
After months or even years of time in-
vested in conducting your evaluation
project, you want to ensure that your re-
sults are put to good use. One way to
accomplish this is to report your results
in written or oral form (Step 4). It is
equally important, however, to explore
what the results mean for your
programme and its service to patients/
clients. Discuss your findings with ex-
pected user(s), community members,
funders, and other important groups. Get
their point of view on what should lie
ahead for your programme. Do changes
need to happen? If so, what is the best
way to accomplish these new goals?
Before making changes in your
programme, it is important to consider the
limitations of your evaluation. If you have
followed the steps outlined in this work-
book series, you can feel reasonably con-
fident in your results. Nonetheless, it may
be prudent to attempt to replicate the
study’s results before making large-scale
changes.
Following discussions, return to the ex-
pected user(s) of the research with spe-
cific recommendations based on your re-
sults. You should have done some of this
work when preparing the written report,
but now it is even more important for you
to be clear and precise. List your recom-
mendations, link them logically to your
results and mutual objectives, and sug-
gest a period for implementation of
changes. The examples below illustrate
this technique.
Based on the finding that clients have to
wait an average of 3,5 months before re-
ceiving an appointment, we recommend
that the programme re-examine its assess-
ment processes, with the goal of short-
ening assessments and/or moving to a
group assessment format. The review
could happen in January, and changes to
the assessment process could happen by
mid-February.
The results indicate that treatment B is
superior to treatment A in terms of reduc-
ing PSU among patients. Therefore, we
recommend that treatment B is offered to
all clients, and that treatment A is reserved
for those who do not show improvement
with treatment B. A follow-up replication
study, starting in April with a new sample
of patients, is also recommended to con-
firm results.
In addition, consider taking your research
results to the public. This can be accom-
plished through the local media, or through
community groups. If approaching the
media, prepare a one page summary state-
ment of your study and its main findings.
(Note: This section
should be reviewed by
all evaluation
partners.)
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If presenting at a community meeting,
highlight the main findings and their im-
plications using an oral presentation. Ei-
ther way, be sure to explain your
programme, the research, and the results
using simple, non-technical language.
Don’t forget to make recommendations,
if appropriate. For example:
Our findings indicate that most people
with PSU problems do better in treat-
ment when supported by a community
member or family member. A trial
programme that included family members
in certain parts of treatment showed
favourable results when compared to
standard, individual PSU treatment.
Into action
Its your turn (5)
The following key recommendations
were formulated by the evaluation team.
1 Based on our findings that the number
of female drug user who enter treat-
ment increased, the service needs to re-
examine if the service meets the need
of female clients.
2 The results indicate that less clients were
referred to long term treatment in com-
parison to the previous year. It is recom-
mended that the service re-examines their
referral process and analyse possible bar-
riers for clients to seek further treatment
and how the service could provide help
to overcome these barriers.
3 The findings show that the number of
self-discharges decreased in compari-
son to the previous year. This repre-
sents a confirmation that the service
provides good withdrawal manage-
ment. accountability requirements, safe
withdrawal from opiates are met.
4 The results support the sufficiency
of the AIDS education intervention.
It is therefore recommended to con-
tinue the intervention and thus pre-
vent further introduction and spread
of HIV among intravenous opiate
users and to prevent HIV transmis-
sion to their sexual partners. A
randomised control trial, starting
next September is recommended to
confirm results.
1 Working individually, think about your
recommendations, based on your treat-
ment research results.  Write down the
recommendations you want to make for
each target audience (e.g., funders, cli-
nicians, patients).
2 Discuss your ideas with your evalu-
ation partners. Arrive at 1-3 key
recommendations for each target
audience.
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Step 6
Start again
In the introduction to the Framework
Workbook, you learned about the impor-
tance of creating a “healthy culture for
evaluation” within your programme.
You learned that a healthy culture for
evaluation is one in which feedback loops
are woven into the fabric of the treatment
service or system. Some feedback loops
serve the purpose of providing basic ac-
countability data to programme or sys-
tem funders, clients and the general pub-
lic. Other feedback loops are better
viewed as the means by which a
programme or treatment system seeks to
continuously improve their services and
outcomes. The steps of planning and
implementing evaluations provide you
with the tools to make this happen in your
own setting.
Remember,
evaluation must
be an attitude
of continually
questioning
and gaining
information.
This final step, Step 6, serves as a reminder
that  feedback also should be directed to-
ward new research and ongoing evalua-
tion of your programme. Remember,
evaluation must be an attitude of continu-
ally questioning and gaining information.
Accordingly, you may want to consider
replicating or extending this evaluation, or
planning a new evaluation to answer a dif-
ferent question. Results from your current
study will help guide you to your next
evaluation activities. The steps outlined in
Workbooks 1 and 2 can help guide future
research efforts. Most important, now that
you have established a culture for evalua-
tion within your setting, you should take
the necessary action to ensure that this
culture remains healthy and strong for the
future.
(Note: This section
should be reviewed by
all evaluation
partners.)
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Into action
Based on their research experience and
their results the evaluation team had the
following ideas for future evaluation
projects:
1 to conduct a randomised control trial
in order to confirm the effectiveness of
the AIDS education intervention.
2 to plan and implement a process evalu-
ation regarding coverage at the activ-
ity level in  order  strengthen the cul-
ture for evaluation within the service.
3 to plan an outcome evaluation regard-
ing illicit substance use, retention,
transfer to further treatment.
1 Based on your overall research ex-
perience and results, what can you
do next? Working individually, write
down one new idea for your next
evaluation research project. Discuss
these ideas with your evaluation
partners and make a plan for how to
proceed.
Its your turn (6)
